Fedora Pharmaceuticals Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $895K

Fedora Pharmaceuticals General Information

Description

Developer of novel antimicrobial agents designed to treat multidrug-resistant infections. The company's technology includes a beta-lactamase inhibitor that selectively and effectively inhibits beta-lactamases and restores the activity of the antibiotics, enabling the healthcare industry to boost antibiotic development to address antimicrobial resistance.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11629 105 Avenue NorthWest
  • Edmonton, Alberta T5H 0L9
  • Canada
+1 (780)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 11629 105 Avenue NorthWest
  • Edmonton, Alberta T5H 0L9
  • Canada
+1 (780)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fedora Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 30-Apr-2025 $895K Completed Generating Revenue
2. Secondary Transaction - Private Completed Startup
1. Angel (individual) 10-May-2013 $197K $197K Completed Startup
To view Fedora Pharmaceuticals’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Fedora Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel antimicrobial agents designed to treat multidrug-resistant infections. The company's technology inclu
Drug Discovery
Edmonton, Canada
5 As of 2026

Paris, France
 

Malvern, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Fedora Pharmaceuticals Competitors (35)

One of Fedora Pharmaceuticals’s 35 competitors is Eligo Bioscience, a Venture Capital-Backed company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Eligo Bioscience Venture Capital-Backed Paris, France
Venatorx Pharmaceuticals Venture Capital-Backed Malvern, PA
NovaBiotics Venture Capital-Backed Aberdeen, United Kingdom
Nosopharm Formerly VC-backed Lyon, France
Prokaryotics Corporation Union, NJ
You’re viewing 5 of 35 competitors. Get the full list »

Fedora Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fedora Pharmaceuticals FAQs

  • When was Fedora Pharmaceuticals founded?

    Fedora Pharmaceuticals was founded in 2012.

  • Where is Fedora Pharmaceuticals headquartered?

    Fedora Pharmaceuticals is headquartered in Edmonton, Canada.

  • What is the size of Fedora Pharmaceuticals?

    Fedora Pharmaceuticals has 5 total employees.

  • What industry is Fedora Pharmaceuticals in?

    Fedora Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Fedora Pharmaceuticals a private or public company?

    Fedora Pharmaceuticals is a Private company.

  • What is Fedora Pharmaceuticals’s current revenue?

    The current revenue for Fedora Pharmaceuticals is .

  • How much funding has Fedora Pharmaceuticals raised over time?

    Fedora Pharmaceuticals has raised $1.09M.

  • Who are Fedora Pharmaceuticals’s competitors?

    Eligo Bioscience, Venatorx Pharmaceuticals, NovaBiotics, Nosopharm, and Prokaryotics are some of the 35 competitors of Fedora Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process